You are here

tivantinib

Daiichi Sankyo sweeps out Pieris drug, 5 others in a Q1 pipeline cleanup

Endpoints

Thu, 05/11/17 - 11:41 am

Daiichi, ArQule cancer drug fails in late-stage study

BioPharma Dive

Sat, 02/18/17 - 02:43 pm

clinical trials

Battered ArQule shares bump up on badly needed positive data for tivantinib

Fierce Biotech

Mon, 11/10/14 - 11:13 am

metastatic prostate cancer

ArQule shares rise after committee say liver cancer study can continue with lower drug dose

Yahoo/AP

Fri, 01/17/14 - 08:39 am

Data on ArQule's Tivantinib

Yahoo/Zacks

Sat, 10/5/13 - 09:18 am

non-small cell lung cancer

ArQule up on hope for lung cancer drug revival

Reuters

Fri, 09/27/13 - 11:51 am

ArQule to cut liver cancer drug dose on safety concerns

Reuters

Tue, 09/3/13 - 04:20 pm

ArQule enrolls first patient in Phase 3 trial for carcinoma candidate tivantinib

Yahoo/Fly on the Wall

Thu, 01/31/13 - 10:48 am

hepatocellular carcinoma

Latest Tivantinib Failure Hits ArQule Despite Its Irrelevance

Seeking Alpha

Tue, 01/15/13 - 11:39 am

colorectal cancer

ArQule's Tivantinib Failure And Exelixis' Cabozantinib PDUFA: Is There A Correlation?

Seeking Alpha

Fri, 10/12/12 - 12:17 pm

non-small cell lung cancer

ArQule stock plunges as lung cancer study shelved

Yahoo/AP

Tue, 10/2/12 - 11:25 am

non-small cell lung cancer

This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib

Motley Fool

Fri, 08/31/12 - 12:27 pm

ArQule Shares Drop on Lung Cancer Drug Safety Concern

Minyanville

Wed, 08/29/12 - 12:17 pm